1. Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells
   Kyosuke Mukae et al, 2023, Cancer Science CrossRef
2. Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
   Keita Sasa et al, 2022, Technology in Cancer Research & Treatment CrossRef
3. Dual responsive hydroxyapatite capped mesoporous silica nanoparticles for controlled delivery of Palbociclib to treat osteosarcoma
   Seyed Reza Heydari et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
4. Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours
   Nil A. Schubert et al, 2022, European Journal of Cancer CrossRef
5. Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes
   Si-Yang Liu et al, 2021, Nature Communications CrossRef
6. Combination of Genomic Landsscape and 3D Culture Functional Assays Bridges Sarcoma Phenotype to Target and Immunotherapy
   Filomena de Nigris et al, 2023, Cells CrossRef
7. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
   Marina Ferreira Candido et al, 2023, Pharmaceutics CrossRef
8. Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
   Margaret E. Macy et al, 2024, JCO Precision Oncology CrossRef
9. The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review
   Victoria L. Tippett et al, 2023, Oncogene CrossRef
10. Effect of adjuvant chemotherapy on localized dedifferentiated low-grade osteosarcoma: a systematic review
    S. Tsukamoto et al, 2024, MUSCULOSKELETAL SURGERY CrossRef
11. Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
    Peng Yan et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
12. Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics
    Nuzhat Bano et al, 2024, Journal of Chemotherapy CrossRef
13. Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance
    Yingfei Xue, 2024, International Journal of Clinical and Experimental Pathology CrossRef
14. NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression
    Qizhi Qin et al, 2022, Cancer Research CrossRef